Braskem Past Earnings Performance

Past criteria checks 0/6

Braskem has been growing earnings at an average annual rate of 4%, while the Chemicals industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 12.1% per year.

Key information

4.0%

Earnings growth rate

4.0%

EPS growth rate

Chemicals Industry Growth12.9%
Revenue growth rate12.1%
Return on equity-149.1%
Net Margin-6.5%
Next Earnings Update08 May 2024

Recent past performance updates

Recent updates

Braskem: A Rising Odds For ADNOC Deal, Though Declining Risk-Reward (Rating Downgrade)

Apr 05

Braskem: Mounting Troubles Impacting Financial Performance

Jan 25

Braskem: Special Situations Trade With 100% Upside Potential

Dec 12

Braskem: Glad I Sold After A 27.8% Negative RoR

Nov 09

Braskem: A Speculative Bet On A Cycle Downturn

Aug 27

Braskem: It's Time To Be Careful After The M&A (Rating Downgrade)

Aug 04

Braskem: 22% RoR Since March, Still A 'Buy' After Q1 2023

May 24

Braskem: Second Look At This International Petrochemical Player After A ~30% Drop

Dec 26

Braskem S.A. GAAP EPS of $1.73 beats by $1.70, revenue of $4.83B beats by $780M

Nov 10

Braskem Buoyed By A Buyout Offer

Oct 13

Braskem: Time To Look Beyond The EU/North America?

Aug 03

Braskem S.A.: Undervalued Moneymaker With Game-Changing Potential

May 18

Braskem: Growth Stock Moving In Line With ESG Commitments

Feb 22

Record Resin Prices Leaving Braskem In Great Shape

Aug 25

Braskem expects to spend 9B reais to address Alagoas geological damage

Dec 31

Braskem: A Justified Valuation Discount

Dec 15

Mexico cuts off gas supply to Braskem plant in escalating dispute

Dec 03

Braskem S.A. beats on revenue

Nov 11

Revenue & Expenses Breakdown
Beta

How Braskem makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:BAK Revenue, expenses and earnings (BRL Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2370,569-4,5794,471383
30 Sep 2372,867-4,7154,638386
30 Jun 2381,579-3,4004,746398
31 Mar 2389,234-4,0354,847395
31 Dec 2296,519-3364,910374
30 Sep 22105,7421,9054,921354
30 Jun 22108,6546,5454,910323
31 Mar 22109,66415,3754,767307
31 Dec 21105,62513,9854,587297
30 Sep 2196,15114,3014,331276
30 Jun 2183,8449,3514,074265
31 Mar 2168,611-5483,908257
31 Dec 2058,543-6,6923,826251
30 Sep 2052,445-10,4603,866251
30 Jun 2049,821-9,9353,952246
31 Mar 2051,970-7,3754,028248
31 Dec 1952,324-2,7984,015248
30 Sep 1954,520463,886235
30 Jun 1957,5002,2783,888244
31 Mar 1957,9492,7413,614235
31 Dec 1858,0002,8673,395219
30 Sep 1855,7923,1143,191210
30 Jun 1851,6052,5692,924181
31 Mar 1849,6903,3292,913173
31 Dec 1749,2613,8572,894167
30 Sep 1748,6781,1532,835153
30 Jun 1748,4981,2382,781152
31 Mar 1748,3495482,754153
31 Dec 1647,664-4382,689162
30 Sep 1647,5472,1882,563170
30 Jun 1648,7292,8702,480170
31 Mar 1648,5993,5562,397172
31 Dec 1546,8802,9952,173170
30 Sep 1546,5622,9652,384157
30 Jun 1545,1231,6672,369154
31 Mar 1544,3847102,380144
31 Dec 1446,0318642,366138
30 Sep 1445,2038122,259138
30 Jun 1444,4179422,196132
31 Mar 1443,3116992,118125
31 Dec 1340,9695102,079116
30 Sep 1340,0654672,163106
30 Jun 1338,381-142,113106

Quality Earnings: BAK is currently unprofitable.

Growing Profit Margin: BAK is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BAK is unprofitable, but has reduced losses over the past 5 years at a rate of 4% per year.

Accelerating Growth: Unable to compare BAK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BAK is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-11.9%).


Return on Equity

High ROE: BAK has a negative Return on Equity (-149.13%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.